Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment.

about

Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro.

P2860

Q35580306-F1494B10-07EB-4F67-9681-911BFB41E7A4

P2860

Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment.

Item

http://www.wikidata.org/entity/Q44222188

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Dasatinib promotes the potenti ...... induction ex vivo environment.

@en

Dasatinib promotes the potenti ...... induction ex vivo environment.

@nl

type

Item

label

Dasatinib promotes the potenti ...... induction ex vivo environment.

@en

Dasatinib promotes the potenti ...... induction ex vivo environment.

@nl

prefLabel

Dasatinib promotes the potenti ...... induction ex vivo environment.

@en

Dasatinib promotes the potenti ...... induction ex vivo environment.

@nl

P1476

Dasatinib promotes the potenti ...... induction ex vivo environment

@en

P2093

B S Wang

http://www.w3.org/2001/XMLSchema#string

H R Fu

http://www.w3.org/2001/XMLSchema#string

K N Wu

http://www.w3.org/2001/XMLSchema#string

L X Sheng

http://www.w3.org/2001/XMLSchema#string

S Fu

http://www.w3.org/2001/XMLSchema#string

Y He

http://www.w3.org/2001/XMLSchema#string

Y J Wang

http://www.w3.org/2001/XMLSchema#string

Y X Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Six-of-the-best: unique contributions of γδ T cells to immunology

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy.

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia.

Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.

The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity.

V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.

Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation.

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients.

Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

P2888

leu.2013.221

P304

206-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2013.221

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

He Huang

P577

2013-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23872992

http://www.w3.org/2001/XMLSchema#string

Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment.

about

P2860

P2860

Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698